Business Context and Reporting Period
Company: Inspire Medical Systems, Inc.
Filing Type: Form 8-K (Current Report)
Date: October 10, 2025
Context: The filing serves as a Regulation FD disclosure to announce the company's participation in investor and analyst meetings in October 2025. It incorporates presentation materials and a press release as exhibits.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of presentation materials rather than a financial results report.
Material Changes
No material financial changes or operational updates are detailed within the text of this specific 8-K filing. The primary event is the scheduled dissemination of investor presentation materials.
Guidance, Outlook, and Risks
Management Commentary: The company is distributing presentation materials to investors and analysts. These materials are available on the company's Investor Relations website.
Legal Disclaimer: The information in Item 7.01 and the attached presentation (Exhibit 99.2) is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.2 (Presentation) and Exhibit 99.1 (Press Release) for specific financial data and strategic updates.
- Verify the content on the official Investor Relations website at https://investors.inspiresleep.com.
- Note that the presentation materials are not legally "filed" for liability purposes under Section 18 of the Exchange Act.